Increased serum OPG in atrophic nonunion shaft fractures

Optimization and Engineering

Volumn 10, Issue 2, 2009, Pages 55-58

  Marchelli, Daniele ^a   Piodi, Luca P ^a   Corradini, Costantino ^b   Parravicini, Luca ^b   Verdoia, Cesare ^b   Ulivieri, Fabio M ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone turnover markers; Nonunion; Osteoprotegerin; Shaft fractures

Indexed keywords

ALKALINE PHOSPHATASE; BONE MARKERS; BONE METABOLISM; BONE REPAIR; BONE TURNOVER MARKERS; LONG BONE; NONUNION; NUCLEAR FACTORS; OSTEOCALCIN; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR; SERUM MARKERS; SHAFT FRACTURES; STATISTICAL ANALYSIS; STEADY STATE;

BIOMARKERS; BODY FLUIDS; BONE; MINING;

FRACTURE;

EID: 67349121004     PISSN: 13894420     EISSN: 15732924     Source Type: Journal    
DOI: 10.1007/s10195-009-0047-5     Document Type: Article

References (13)

1. Brumback RJ, Ellison TS, Poka A et al (1992) Intramedullary nailing of femoral fractures. Part III: Long-term effects of static interlocking fixation. J Bone Joint Surg 74A:106-112
2. Brownlow HC, Reed A, Simpson AH (2001) Growth factor during the development of atrophic non-union. Injury 32(7):519-524
3. Reed A, Joyner CJ, Brownlow HC et al (2002) Human atrophic fracture non-unions are not avascular. J Orthop Res 20:593-599
4. Brownlow HC, Reed A, Simpson AH (2002) The vascularity of atrophic non-unions. Injury 33:145-150
5. Oh ES, Rhee E-J, Oh KW et al (2005) Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women. Metabolism 54:49-54
6. Hofbauer LC, Heufelder AE (2000) The role of receptor activator of nuclear factor-kB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocrinol Metab 85(7):2355-2363
7. Hofbauer LC, Schoppet M (2001) Serum measurement of osteoprotegerin - clinical relevance and potential applications. Eur J Endocrinol 145:681-683
8. Theoleyre S, Wittrant Y, Tat SK et al (2004) The molecular triad OPG/ RANK/RANKL: Involvement in the orchestration of pathophysiological bone remodelling. Cytokine Growth Factor Rev 15:457-475
9. Nyman MT, Paavolainen P, Forsius S et al (1991) Clinical evaluation of fracture healing by serum osteocalcin and alkaline phosphatase. Ann Chir Gynaecol 80(3):289-293
10. Southwood LL, Frisbie DD, Kawcak CE et al (2003) Evaluation of serum biochemical markers of bone metabolism for early diagnosis of non-union and infected non-union fracture in rabbits. J Am Vet Med Assoc 64(6):727-735
11. Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319
12. Ripamonti U (2006) Soluble osteogenic molecular signals and the induction of bone formation. Biomaterials 27:807-822
13. Szulc P, Hofbauer LC, Heufelder AE et al (2001) Osteoprotegerin serum levels in men: Correlation with age, estrogen and testosterone status. J Clin Endocrinol Metab 86(7):3162-3165